Analyst ratings
Across 29 analysts the consensus is a Strong Buy: 23 buy calls against 2 sell, with an average 12-month price target of $569.19.
NASDAQ: VRTX · Biotechnology
Over the past week, Vertex Pharmaceuticals (VRTX) drew about 35 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 61% bullish but is far apart: X runs 91% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 23 of 29 analysts rating VRTX a buy.
There is little buzz around VRTX this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 79% buy share sits next to a crowd that ranges from Reddit at 0% to X at 91%. No other tracker puts the two side by side.
Across 29 analysts the consensus is a Strong Buy: 23 buy calls against 2 sell, with an average 12-month price target of $569.19.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 18 points above the crowd average of 61%, the professionals are more constructive than retail. The split is inside the crowd: X reads 91% bullish while Reddit sits at 0%, a 91-point spread that single-source trackers miss.
Over the 30-day window, Vertex Pharmaceuticals (VRTX) buzz held moderate around 51.4 while the price drifted down 0.2% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1M shares. Over the last 7 trading days, VRTX lost 7.4%. Buzz activity in the recent week averaged 45.4 and was variable, swinging between 32.4 and 66.1. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 17 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for VRTX and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live VRTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 11, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (23 / 4 / 2) |
| Crowd bullish (7d) | 61% |
| Avg price target | $569.19 |
| Most bullish source | X, 91% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 91 pts |
| Mentions (7d) | 35 |
| Market cap | $130.42B |
| P/E · Forward P/E | 30.4 · 24.3 |
| EPS · Beta | $16.93 · 0.3 |
| Revenue (TTM) | $12.59B · 35% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Vertex Pharmaceuticals (VRTX) currently carries an Adanos hold signal with 66/100 conviction. The current cross-source average reads 61% bullish across 3 active sources. Those sources contribute 35 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Vertex Pharmaceuticals (VRTX) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 6 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Vertex Pharmaceuticals (VRTX), averaging 61% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 91% bullish and Reddit at 0%, a 91-point spread. On the professional side, 23 of 29 analysts rate VRTX a buy.
Of the 29 analysts covering Vertex Pharmaceuticals (VRTX), 23 rate it a buy, 4 a hold and 2 a sell, for a strong buy consensus. The average price target is $569.19. That puts the street ahead of the crowd, which averages 61% bullish.
Vertex Pharmaceuticals (VRTX)'s cross-source average is bullish at 61% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. X reads 91% bullish, News reads 91% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 66/100 conviction.
The cross-source average is bullish for Vertex Pharmaceuticals (VRTX) at 61% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling across X and News. The hold signal carries 66/100 conviction.
News is the dominant discussion channel with 23 mentions (66% of total volume). X contributes 11 mentions and Reddit contributes 1 mention. The cross-source average is bullish at 61% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. VRTX's hold signal at 66/100 conviction reflects a bullish cross-source average at 61% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The VRTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key